Covered recipient · General Payments record
GARY STEINBERG
Allopathic & Osteopathic Physicians Urology
General Payments · PY2018–2024
$542,683.99
- Reported across 299 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $8,806.00 | 5 |
| Honoraria | $2,340.00 | 1 |
| Food and Beverage | $255.07 | 6 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Endo USA, Inc. | $4,250.00 | 2 |
| PFIZER INC. | $2,506.80 | 5 |
| IMMUNITYBIO, INC. | $2,400.00 | 1 |
| Acerta Pharma LLC | $1,668.29 | 2 |
| Merck Sharp & Dohme Corporation | $545.00 | 1 |
| UROGEN PHARMA, INC. | $30.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $57.29 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105418890 | CMS |
| AstraZeneca Pharmaceuticals LP | $1,611.00 | 12/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104684175 | CMS |
| Endo USA, Inc. | $3,450.00 | 05/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1138588374 | CMS |
| Endo USA, Inc. | $800.00 | 12/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1138588376 | CMS |
| IMMUNITYBIO, INC. | $2,400.00 | 06/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125509150 | CMS |
| Merck Sharp & Dohme LLC | $545.00 | 12/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141822005 | CMS |
| PFIZER INC. | $23.30 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131321707 | CMS |
| PFIZER INC. | $71.24 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131467883 | CMS |
| PFIZER INC. | $39.11 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131467887 | CMS |
| PFIZER INC. | $2,340.00 | 06/19/2024 | Honoraria | Undisputed | 01/23/2026 | 1131394452 | CMS |
| PFIZER INC. | $33.15 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131382637 | CMS |
| UROGEN PHARMA, INC. | $30.98 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137932160 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.